Literature DB >> 26147678

Organ-specific differences in achieving tolerance.

Maria Lucia L Madariaga1, Daniel Kreisel, Joren C Madsen.   

Abstract

PURPOSE OF REVIEW: When it comes to tolerance induction, kidney allografts behave differently from heart allografts that behave differently from lung allografts. Here, we examine how and why different organ allografts respond differently to the same tolerance induction protocol. RECENT
FINDINGS: Allograft tolerance has been achieved in experimental and clinical kidney transplantation. Inducing tolerance in experimental recipients of heart and lung allografts has, however, proven to be more challenging. New protocols being developed in nonhuman primates based on mixed chimerism and cotransplantation of tolerogenic organs may provide mechanistic insights to help overcome these challenges.
SUMMARY: Tolerance induction protocols that are successful in patients transplanted with 'tolerance-prone' organs such as kidneys and livers will most likely not succeed in recipients of 'tolerance-resistant' organs such as hearts and lungs. Separate clinical trials using more robust tolerance protocols will be required to achieve tolerance in heart and lung recipients.

Entities:  

Mesh:

Year:  2015        PMID: 26147678      PMCID: PMC4523268          DOI: 10.1097/MOT.0000000000000206

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  114 in total

1.  Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition.

Authors:  Venu G Pillarisetty; Alaap B Shah; George Miller; Joshua I Bleier; Ronald P DeMatteo
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

2.  Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells.

Authors:  Alexander Sasha Krupnick; Andrew E Gelman; Winfried Barchet; Steve Richardson; Friederike H Kreisel; Laurence A Turka; Marco Colonna; G Alexander Patterson; Daniel Kreisel
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

3.  A randomised controlled trial of total immunosuppression withdrawal in stable liver transplant recipients.

Authors:  N Assy; P C Adams; P Myers; V Simon; C N Ghent
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

4.  Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells.

Authors:  Maria T Pallotta; Ciriana Orabona; Claudia Volpi; Carmine Vacca; Maria L Belladonna; Roberta Bianchi; Giuseppe Servillo; Cinzia Brunacci; Mario Calvitti; Silvio Bicciato; Emilia M C Mazza; Louis Boon; Fabio Grassi; Maria C Fioretti; Francesca Fallarino; Paolo Puccetti; Ursula Grohmann
Journal:  Nat Immunol       Date:  2011-07-31       Impact factor: 25.606

5.  Donor brain death significantly interferes with tolerance induction protocols.

Authors:  Maja Francuski; Anja Reutzel-Selke; Sascha Weiss; Andreas Pascher; Anke Jurisch; Frank Ulrich; Guido Schumacher; Wladimir Faber; Sven Kohler; Hans-Dieter Volk; Peter Neuhaus; Stefan G Tullius; Johann Pratschke
Journal:  Transpl Int       Date:  2008-10-23       Impact factor: 3.782

6.  The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity.

Authors:  David G Bowen; Monica Zen; Lauren Holz; Thomas Davis; Geoffrey W McCaughan; Patrick Bertolino
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

7.  Induction of cardiac allograft tolerance across a full MHC barrier in miniature swine by donor kidney cotransplantation.

Authors:  M L Madariaga; S G Michel; M Tasaki; V Villani; G M La Muraglia; S Sihag; J Gottschall; E A Farkash; A Shimizu; J S Allan; D H Sachs; K Yamada; J C Madsen
Journal:  Am J Transplant       Date:  2013-08-22       Impact factor: 8.086

8.  The graft helps to define the character of the alloimmune response.

Authors:  Alice A Bickerstaff; Jiao-Jing Wang; Ronald P Pelletier; Charles G Orosz
Journal:  Transpl Immunol       Date:  2002-05       Impact factor: 1.708

9.  New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells.

Authors:  W Li; C S Kuhr; X X Zheng; K Carper; A W Thomson; J D Reyes; J D Perkins
Journal:  Am J Transplant       Date:  2008-06-12       Impact factor: 8.086

10.  Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.

Authors:  Nan Zhang; Bernd Schröppel; Girdhari Lal; Claudia Jakubzick; Xia Mao; Dan Chen; Na Yin; Rolf Jessberger; Jordi C Ochando; Yaozhong Ding; Jonathan S Bromberg
Journal:  Immunity       Date:  2009-03-20       Impact factor: 31.745

View more
  18 in total

Review 1.  Why some organ allografts are tolerated better than others: new insights for an old question.

Authors:  Travis D Hull; Gilles Benichou; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

2.  Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model.

Authors:  Qi Liu; Xiang Wang; Xiangsheng Liu; Sanjan Kumar; Grant Gochman; Ying Ji; Yu-Pei Liao; Chong Hyun Chang; Wesley Situ; Jianqin Lu; Jinhong Jiang; Kuo-Ching Mei; Huan Meng; Tian Xia; Andre E Nel
Journal:  ACS Nano       Date:  2019-04-12       Impact factor: 15.881

Review 3.  Advances in the immunology of heart transplantation.

Authors:  Joren C Madsen
Journal:  J Heart Lung Transplant       Date:  2017-10-20       Impact factor: 10.247

Review 4.  Translational impact of NIH-funded nonhuman primate research in transplantation.

Authors:  Stuart J Knechtle; Julia M Shaw; Bernhard J Hering; Kristy Kraemer; Joren C Madsen
Journal:  Sci Transl Med       Date:  2019-07-10       Impact factor: 17.956

Review 5.  Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation.

Authors:  Zachary Fitch; Robin Schmitz; Jean Kwun; Bernhard Hering; Joren Madsen; Stuart J Knechtle
Journal:  Transplant Rev (Orlando)       Date:  2019-04-05       Impact factor: 3.943

6.  Ischemia reperfusion injury facilitates lung allograft acceptance through IL-33-mediated activation of donor-derived IL-5 producing group 2 innate lymphoid cells.

Authors:  Yizhan Guo; Zhongcheng Mei; Dongge Li; Anirban Banerjee; May A Khalil; Allen Burke; Jon Ritter; Christine Lau; Daniel Kreisel; Andrew E Gelman; Elizabeth Jacobsen; Irina G Luzina; Sergei P Atamas; Alexander Sasha Krupnick
Journal:  Am J Transplant       Date:  2022-05-17       Impact factor: 9.369

7.  Incomplete clonal deletion as prerequisite for tissue-specific minor antigen tolerization.

Authors:  Nina Pilat; Benedikt Mahr; Lukas Unger; Karin Hock; Christoph Schwarz; Andreas M Farkas; Ulrike Baranyi; Fritz Wrba; Thomas Wekerle
Journal:  JCI Insight       Date:  2016-05-19

8.  Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy.

Authors:  Osama Mohamad; Alberto Diaz de Leon; Samuel Schroeder; Andrew Leiker; Alana Christie; Elizabeth Zhang-Velten; Lakshya Trivedi; Saad Khan; Neil B Desai; Aaron Laine; Kevin Albuquerque; Puneeth Iyengar; Yull Arriaga; Kevin Courtney; David E Gerber; Hans Hammers; Hak Choy; Robert Timmerman; James Brugarolas; Raquibul Hannan
Journal:  Oncoimmunology       Date:  2018-03-15       Impact factor: 8.110

9.  The effects of brain death and ischemia on tolerance induction are organ-specific.

Authors:  S G Michel; M L L Madariaga; G M LaMuraglia; V Villani; M Sekijima; E A Farkash; R B Colvin; D H Sachs; K Yamada; B R Rosengard; J S Allan; J C Madsen
Journal:  Am J Transplant       Date:  2018-03-05       Impact factor: 8.086

10.  A Mixed-chimerism Protocol Utilizing Thymoglobulin and Belatacept Did Not Induce Lung Allograft Tolerance, Despite Previous Success in Renal Allotransplantation.

Authors:  Wiebke Sommer; Jane M O; Kurt B Pruner; Abbas Dehnadi; Kyu Ha Huh; Kortney A Robinson; Isabel Hanekamp; Ivy Rosales; Alison S Bean; Josh Paster; Tetsu Oura; Rex Neal Smith; Robert Colvin; Gilles Benichou; Tatsuo Kawai; Joren C Madsen; James S Allan
Journal:  Transplant Direct       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.